Site-specific MOF-based immunotherapeutic nanoplatforms by way of hand in hand cancer cells-targeted treatment method and also dendritic cells-targeted immunomodulation. | #GSK3326595 #PGE2 #YC-1 #Chidamide #AMD3100 #MLN7243 #ARN-509 #E64d #CIL56 #IPI-549 #666-15 #TG101348 #ORY-1001 #ONC201 #FTY720 #ODM-201 #STZ #FDA-approved Drug Library #MEK inhibitor #Raf inhibitor
